Revenue: The sum of all revenue fields included for a company's operating activities.
AN2 Therapeutics, Inc. (ANTX) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-8.19M |
|
-- |
|
-- |
|
$8.90M |
|
$-8.90M |
|
$0.72M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.19M |
|
$-8.90M |
|
$-9.00M |
|
44.76M |
|
44.76M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$79.99M |
|
-- |
|
$1.69M |
|
$81.68M |
|
$5.58M |
|
-- |
|
$0.17M |
|
$5.75M |
|
$75.92M |
|
$75.92M |
|
$75.92M |
|
36.31M |
|
| Cash Flow Statement Financials | |
$-19.07M |
|
$4.63M |
|
$38.82M |
|
$19.94M |
|
$44.32M |
|
$24.38M |
|
$2.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.78% |
|
-10.78% |
|
-10.02% |
|
-10.78% |
|
$2.09 |
|
$-0.43 |
|
$-0.43 |
|